NEVVI Medicare utilization intelligence
or

← back

Provider profile

SOTOS, GEORGE M.D.

Hematology-Oncology · NPI 1033290705 · ROCKVILLE, MD

1
Groups
66
Codes · 2024
91,451
Disclosed services

SOTOS, GEORGE is a Hematology-Oncology in ROCKVILLE, MD, a member of 1 medical group, who billed 66 distinct codes to Medicare Part B in 2024.

Groups: MARYLAND ONCOLOGY HEMATOLOGY PA (LAUREL, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

91,451
disclosed services
66
codes billed to Medicare Part B
Prior year · CY2023 105,486 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9025 Injection, azacitidine, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J9041 Injection, bortezomib, 0.1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
82784 Gammaglobulin (immune system protein) measurement
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
J2469 Injection, palonosetron hcl, 25 mcg
J9190 Injection, fluorouracil, 500 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
88185 Flow cytometry technique for dna or cell analysis, each additional marker
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J9045 Injection, carboplatin, 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83520 Measurement of substance using immunoassay technique
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
82378 Carcinoembryonic antigen (cea) protein level
83615 Lactate dehydrogenase (enzyme) level
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96415 Administration of chemotherapy into vein, each additional hour
36415 Insertion of needle into vein for collection of blood sample
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J3489 Injection, zoledronic acid, 1 mg
84550 Uric acid level, blood
99441 Telephone medical discussion with physician, 5-10 minutes
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99442 Telephone medical discussion with physician, 11-20 minutes
J3490 Unclassified drugs
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96411 Administration of additional new drug or substance into vein using push technique
J7030 Infusion, normal saline solution , 1000 cc
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
83010 Haptoglobin (serum protein) level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
96523 Irrigation of implanted venous access drug delivery device
96361 Infusion into a vein for hydration, each additional hour
83735 Magnesium level
96360 Infusion into a vein for hydration, 31-60 minutes
96416 Administration of prolonged chemotherapy into vein
99195 Drawing of blood for a medical problem
88184 Flow cytometry technique for dna or cell analysis, first marker
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.